Company / Current Liabilities per Share
Fulgent Genetics, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.76
FY2025
5-year range
$2.46 / $3.74
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
#107 of 158
Health Care
What the data says
At $2.76, Fulgent Genetics, Inc.'s current liabilities per share ranks #52 of 158 in the Health Care sector. Current Liabilities per Share returned to growth in FY2025 after 4 years of decline, reaching $2.76.
Based on SEC 10-K filings.
2.76 in FY2025 with a 5-year CAGR of -14.6%.
Increased from $2.48 to $2.76 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- -14.6%
- 10-Year CAGR
- -
Sector benchmark
#52 of 158 in Health CareTop 32% of 158This company $2.76 Sector average $29.75
▼
-90.7% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 12.1% year-over-year.
- Ranks #107 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.76 | +12.1% |
| FY2024 | $2.46 | -0.9% |
| FY2023 | $2.48 | -15.1% |
| FY2022 | $2.92 | -21.8% |
| FY2021 | $3.74 | -38.3% |
| FY2020 | $6.06 | +2856.3% |
| FY2019 | $0.20 | +33.5% |
| FY2018 | $0.15 | -9.6% |
| FY2017 | $0.17 | -9.5% |
| FY2016 | $0.19 | +223.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026